Pfizer's Stock Gains Momentum, Closing Gap with Amgen
Update: 2025-11-28
Description
Pfizer, a global biopharmaceutical giant, has recently seen a positive shift in its stock performance, trading above its moving averages for the first time in a while. Despite facing challenges in attracting investor interest, Pfizers stock has started to gain momentum, potentially closing the gap with its competitors like Amgen, which has seen remarkable growth in the past year.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
